0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Patient Recruitment for Clinical Trials Market Research Report 2026
Published Date: 2026-01-19
|
Report Code: QYRE-Auto-23W10350
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Patient Recruitment for Clinical Trials Market Research Report 2022
BUY CHAPTERS

Global Patient Recruitment for Clinical Trials Market Research Report 2026

Code: QYRE-Auto-23W10350
Report
2026-01-19
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Patient Recruitment for Clinical Trials Market Size

The global Patient Recruitment for Clinical Trials market was valued at US$ 3476 million in 2025 and is anticipated to reach US$ 6851 million by 2032, at a CAGR of 10.0% from 2026 to 2032.

Patient Recruitment for Clinical Trials Market

Patient Recruitment for Clinical Trials Market

Patient recruitment for clinical trials refers to specialized services that support the identification, screening, enrollment, and management of study participants for clinical research projects. These services typically involve multi-channel patient outreach, eligibility pre-screening, informed consent support, and enrollment tracking, enabling sponsors, CROs, and research sites to meet recruitment targets within required timelines while ensuring protocol compliance and data quality.
The market is primarily driven by the increasing number and complexity of clinical trials. Rising investment in drug development and the rapid growth of innovative therapies—such as oncology, rare diseases, biologics, and cell and gene therapies—have led to stricter inclusion/exclusion criteria and more fragmented patient populations, increasing reliance on professional recruitment services. In parallel, pressure to reduce trial timelines and costs encourages sponsors to outsource recruitment to specialized providers with data-driven and operational expertise. The adoption of digital recruitment tools, real-world data, and patient-centric engagement strategies further improves recruitment efficiency and reach, supporting continued market growth.
In global market, the largest three players are IQVIA, Thermo Fisher Scientific (PPD), and ICON plc, hold 28 percent of global market in 2024; while in China market, the largest three players are Baidu Health, Hangzhou Tigermed, occupied for more than 14% of China market in 2024.
This report delivers a comprehensive overview of the global Patient Recruitment for Clinical Trials market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Patient Recruitment for Clinical Trials. The Patient Recruitment for Clinical Trials market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Patient Recruitment for Clinical Trials market comprehensively. Regional market sizes by Clinical Trial Phase, by Therapeutic Area, by Client Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Patient Recruitment for Clinical Trials manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Clinical Trial Phase, by Therapeutic Area, and by region.
Market Segmentation

Scope of Patient Recruitment for Clinical Trials Market Report

Report Metric Details
Report Name Patient Recruitment for Clinical Trials Market
Accounted market size in 2025 US$ 3476 million
Forecasted market size in 2032 US$ 6851 million
CAGR 10.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Clinical Trial Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Segment by Client Type
  • Pharmaceutical and Biotechnology Companies
  • CROs and Research Organizations
  • Others
Segment by Recruitment Channel
  • Online
  • Offline
Segment by Therapeutic Area
  • Oncology
  • Rare Disease
  • CNS and Psychiatric
  • Inflammatory Disorder
  • Infectious Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IQVIA, Thermo Fisher Scientific (PPD), ICON plc, Syneos Health, Parexel, Labcorp, Medpace, Inc., WCG Clinical, Science37, Baidu Health, Hangzhou Tigermed, AutoCruitment, Beijing Houpu Pharmaceutical, Clariness, Matthews Media Group (MMG), Trialbee, Publicis, Worldwide Clinical Trials, Elixia, Shanghai Jsure, JD Health, Waterdrop Inc., Antidote
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Clinical Trial Phase, by Therapeutic Area, by Client Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Patient Recruitment for Clinical Trials companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Clinical Trial Phase, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Therapeutic Area, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Patient Recruitment for Clinical Trials Market growing?

Ans: The Patient Recruitment for Clinical Trials Market witnessing a CAGR of 10.0% during the forecast period 2026-2032.

What is the Patient Recruitment for Clinical Trials Market size in 2032?

Ans: The Patient Recruitment for Clinical Trials Market size in 2032 will be US$ 6851 million.

Who are the main players in the Patient Recruitment for Clinical Trials Market report?

Ans: The main players in the Patient Recruitment for Clinical Trials Market are IQVIA, Thermo Fisher Scientific (PPD), ICON plc, Syneos Health, Parexel, Labcorp, Medpace, Inc., WCG Clinical, Science37, Baidu Health, Hangzhou Tigermed, AutoCruitment, Beijing Houpu Pharmaceutical, Clariness, Matthews Media Group (MMG), Trialbee, Publicis, Worldwide Clinical Trials, Elixia, Shanghai Jsure, JD Health, Waterdrop Inc., Antidote

What are the Type segmentation covered in the Patient Recruitment for Clinical Trials Market report?

Ans: The Types covered in the Patient Recruitment for Clinical Trials Market report are Pharmaceutical and Biotechnology Companies, CROs and Research Organizations, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Clinical Trial Phase
1.2.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Clinical Trial Phase: 2021 vs 2025 vs 2032
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Client Type
1.3.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Client Type: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 CROs and Research Organizations
1.3.4 Others
1.4 Market by Recruitment Channel
1.4.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Recruitment Channel: 2021 vs 2025 vs 2032
1.4.2 Online
1.4.3 Offline
1.5 Market by Therapeutic Area
1.5.1 Global Patient Recruitment for Clinical Trials Market Growth by Therapeutic Area: 2021 vs 2025 vs 2032
1.5.2 Oncology
1.5.3 Rare Disease
1.5.4 CNS and Psychiatric
1.5.5 Inflammatory Disorder
1.5.6 Infectious Disease
1.5.7 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Patient Recruitment for Clinical Trials Market Perspective (2021–2032)
2.2 Global Patient Recruitment for Clinical Trials Growth Trends by Region
2.2.1 Global Patient Recruitment for Clinical Trials Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Patient Recruitment for Clinical Trials Historic Market Size by Region (2021–2026)
2.2.3 Patient Recruitment for Clinical Trials Forecasted Market Size by Region (2027–2032)
2.3 Patient Recruitment for Clinical Trials Market Dynamics
2.3.1 Patient Recruitment for Clinical Trials Industry Trends
2.3.2 Patient Recruitment for Clinical Trials Market Drivers
2.3.3 Patient Recruitment for Clinical Trials Market Challenges
2.3.4 Patient Recruitment for Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue
3.1.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue (2021–2026)
3.1.2 Global Patient Recruitment for Clinical Trials Revenue Market Share by Players (2021–2026)
3.2 Global Top Patient Recruitment for Clinical Trials Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Patient Recruitment for Clinical Trials Revenue
3.4 Global Patient Recruitment for Clinical Trials Market Concentration Ratio
3.4.1 Global Patient Recruitment for Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Recruitment for Clinical Trials Revenue in 2025
3.5 Global Key Players of Patient Recruitment for Clinical Trials Head Offices and Areas Served
3.6 Global Key Players of Patient Recruitment for Clinical Trials, Products and Applications
3.7 Global Key Players of Patient Recruitment for Clinical Trials, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Patient Recruitment for Clinical Trials Breakdown Data by Clinical Trial Phase
4.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Clinical Trial Phase (2021–2026)
4.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Clinical Trial Phase (2027–2032)
5 Patient Recruitment for Clinical Trials Breakdown Data by Therapeutic Area
5.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Therapeutic Area (2021–2026)
5.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Therapeutic Area (2027–2032)
6 North America
6.1 North America Patient Recruitment for Clinical Trials Market Size (2021–2032)
6.2 North America Patient Recruitment for Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Patient Recruitment for Clinical Trials Market Size by Country (2021–2026)
6.4 North America Patient Recruitment for Clinical Trials Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Patient Recruitment for Clinical Trials Market Size (2021–2032)
7.2 Europe Patient Recruitment for Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Patient Recruitment for Clinical Trials Market Size by Country (2021–2026)
7.4 Europe Patient Recruitment for Clinical Trials Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size (2021–2032)
8.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (2021–2026)
8.4 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Patient Recruitment for Clinical Trials Market Size (2021–2032)
9.2 Latin America Patient Recruitment for Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2021–2026)
9.4 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size (2021–2032)
10.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2021–2026)
10.4 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Patient Recruitment for Clinical Trials Introduction
11.1.4 IQVIA Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.1.5 IQVIA Recent Development
11.2 Thermo Fisher Scientific (PPD)
11.2.1 Thermo Fisher Scientific (PPD) Company Details
11.2.2 Thermo Fisher Scientific (PPD) Business Overview
11.2.3 Thermo Fisher Scientific (PPD) Patient Recruitment for Clinical Trials Introduction
11.2.4 Thermo Fisher Scientific (PPD) Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.2.5 Thermo Fisher Scientific (PPD) Recent Development
11.3 ICON plc
11.3.1 ICON plc Company Details
11.3.2 ICON plc Business Overview
11.3.3 ICON plc Patient Recruitment for Clinical Trials Introduction
11.3.4 ICON plc Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.3.5 ICON plc Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Details
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health Patient Recruitment for Clinical Trials Introduction
11.4.4 Syneos Health Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.4.5 Syneos Health Recent Development
11.5 Parexel
11.5.1 Parexel Company Details
11.5.2 Parexel Business Overview
11.5.3 Parexel Patient Recruitment for Clinical Trials Introduction
11.5.4 Parexel Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.5.5 Parexel Recent Development
11.6 Labcorp
11.6.1 Labcorp Company Details
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Patient Recruitment for Clinical Trials Introduction
11.6.4 Labcorp Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.6.5 Labcorp Recent Development
11.7 Medpace, Inc.
11.7.1 Medpace, Inc. Company Details
11.7.2 Medpace, Inc. Business Overview
11.7.3 Medpace, Inc. Patient Recruitment for Clinical Trials Introduction
11.7.4 Medpace, Inc. Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.7.5 Medpace, Inc. Recent Development
11.8 WCG Clinical
11.8.1 WCG Clinical Company Details
11.8.2 WCG Clinical Business Overview
11.8.3 WCG Clinical Patient Recruitment for Clinical Trials Introduction
11.8.4 WCG Clinical Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.8.5 WCG Clinical Recent Development
11.9 Science37
11.9.1 Science37 Company Details
11.9.2 Science37 Business Overview
11.9.3 Science37 Patient Recruitment for Clinical Trials Introduction
11.9.4 Science37 Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.9.5 Science37 Recent Development
11.10 Baidu Health
11.10.1 Baidu Health Company Details
11.10.2 Baidu Health Business Overview
11.10.3 Baidu Health Patient Recruitment for Clinical Trials Introduction
11.10.4 Baidu Health Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.10.5 Baidu Health Recent Development
11.11 Hangzhou Tigermed
11.11.1 Hangzhou Tigermed Company Details
11.11.2 Hangzhou Tigermed Business Overview
11.11.3 Hangzhou Tigermed Patient Recruitment for Clinical Trials Introduction
11.11.4 Hangzhou Tigermed Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.11.5 Hangzhou Tigermed Recent Development
11.12 AutoCruitment
11.12.1 AutoCruitment Company Details
11.12.2 AutoCruitment Business Overview
11.12.3 AutoCruitment Patient Recruitment for Clinical Trials Introduction
11.12.4 AutoCruitment Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.12.5 AutoCruitment Recent Development
11.13 Beijing Houpu Pharmaceutical
11.13.1 Beijing Houpu Pharmaceutical Company Details
11.13.2 Beijing Houpu Pharmaceutical Business Overview
11.13.3 Beijing Houpu Pharmaceutical Patient Recruitment for Clinical Trials Introduction
11.13.4 Beijing Houpu Pharmaceutical Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.13.5 Beijing Houpu Pharmaceutical Recent Development
11.14 Clariness
11.14.1 Clariness Company Details
11.14.2 Clariness Business Overview
11.14.3 Clariness Patient Recruitment for Clinical Trials Introduction
11.14.4 Clariness Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.14.5 Clariness Recent Development
11.15 Matthews Media Group (MMG)
11.15.1 Matthews Media Group (MMG) Company Details
11.15.2 Matthews Media Group (MMG) Business Overview
11.15.3 Matthews Media Group (MMG) Patient Recruitment for Clinical Trials Introduction
11.15.4 Matthews Media Group (MMG) Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.15.5 Matthews Media Group (MMG) Recent Development
11.16 Trialbee
11.16.1 Trialbee Company Details
11.16.2 Trialbee Business Overview
11.16.3 Trialbee Patient Recruitment for Clinical Trials Introduction
11.16.4 Trialbee Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.16.5 Trialbee Recent Development
11.17 Publicis
11.17.1 Publicis Company Details
11.17.2 Publicis Business Overview
11.17.3 Publicis Patient Recruitment for Clinical Trials Introduction
11.17.4 Publicis Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.17.5 Publicis Recent Development
11.18 Worldwide Clinical Trials
11.18.1 Worldwide Clinical Trials Company Details
11.18.2 Worldwide Clinical Trials Business Overview
11.18.3 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Introduction
11.18.4 Worldwide Clinical Trials Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.18.5 Worldwide Clinical Trials Recent Development
11.19 Elixia
11.19.1 Elixia Company Details
11.19.2 Elixia Business Overview
11.19.3 Elixia Patient Recruitment for Clinical Trials Introduction
11.19.4 Elixia Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.19.5 Elixia Recent Development
11.20 Shanghai Jsure
11.20.1 Shanghai Jsure Company Details
11.20.2 Shanghai Jsure Business Overview
11.20.3 Shanghai Jsure Patient Recruitment for Clinical Trials Introduction
11.20.4 Shanghai Jsure Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.20.5 Shanghai Jsure Recent Development
11.21 JD Health
11.21.1 JD Health Company Details
11.21.2 JD Health Business Overview
11.21.3 JD Health Patient Recruitment for Clinical Trials Introduction
11.21.4 JD Health Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.21.5 JD Health Recent Development
11.22 Waterdrop Inc.
11.22.1 Waterdrop Inc. Company Details
11.22.2 Waterdrop Inc. Business Overview
11.22.3 Waterdrop Inc. Patient Recruitment for Clinical Trials Introduction
11.22.4 Waterdrop Inc. Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.22.5 Waterdrop Inc. Recent Development
11.23 Antidote
11.23.1 Antidote Company Details
11.23.2 Antidote Business Overview
11.23.3 Antidote Patient Recruitment for Clinical Trials Introduction
11.23.4 Antidote Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.23.5 Antidote Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Clinical Trial Phase (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Phase I
 Table 3. Key Players of Phase II
 Table 4. Key Players of Phase III
 Table 5. Key Players of Phase IV
 Table 6. Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Client Type (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Key Players of Pharmaceutical and Biotechnology Companies
 Table 8. Key Players of CROs and Research Organizations
 Table 9. Key Players of Others
 Table 10. Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Recruitment Channel (US$ Million): 2021 vs 2025 vs 2032
 Table 11. Key Players of Online
 Table 12. Key Players of Offline
 Table 13. Global Patient Recruitment for Clinical Trials Market Size Growth by Therapeutic Area (US$ Million): 2021 vs 2025 vs 2032
 Table 14. Global Patient Recruitment for Clinical Trials Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 15. Global Patient Recruitment for Clinical Trials Market Size by Region (US$ Million), 2021–2026
 Table 16. Global Patient Recruitment for Clinical Trials Market Share by Region (2021–2026)
 Table 17. Global Patient Recruitment for Clinical Trials Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 18. Global Patient Recruitment for Clinical Trials Market Share by Region (2027–2032)
 Table 19. Patient Recruitment for Clinical Trials Market Trends
 Table 20. Patient Recruitment for Clinical Trials Market Drivers
 Table 21. Patient Recruitment for Clinical Trials Market Challenges
 Table 22. Patient Recruitment for Clinical Trials Market Restraints
 Table 23. Global Patient Recruitment for Clinical Trials Revenue by Players (US$ Million), 2021–2026
 Table 24. Global Patient Recruitment for Clinical Trials Market Share by Players (2021–2026)
 Table 25. Global Top Patient Recruitment for Clinical Trials Players by Tier (Tier 1, Tier 2, and Tier 3), based on Patient Recruitment for Clinical Trials Revenue, 2025
 Table 26. Ranking of Global Top Patient Recruitment for Clinical Trials Companies by Revenue (US$ Million) in 2025
 Table 27. Global 5 Largest Players Market Share by Patient Recruitment for Clinical Trials Revenue (CR5 and HHI), 2021–2026
 Table 28. Global Key Players of Patient Recruitment for Clinical Trials, Headquarters and Area Served
 Table 29. Global Key Players of Patient Recruitment for Clinical Trials, Products and Applications
 Table 30. Global Key Players of Patient Recruitment for Clinical Trials, Date of General Availability (GA)
 Table 31. Mergers and Acquisitions, Expansion Plans
 Table 32. Global Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (US$ Million), 2021–2026
 Table 33. Global Patient Recruitment for Clinical Trials Revenue Market Share by Clinical Trial Phase (2021–2026)
 Table 34. Global Patient Recruitment for Clinical Trials Forecasted Market Size by Clinical Trial Phase (US$ Million), 2027–2032
 Table 35. Global Patient Recruitment for Clinical Trials Revenue Market Share by Clinical Trial Phase (2027–2032)
 Table 36. Global Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (US$ Million), 2021–2026
 Table 37. Global Patient Recruitment for Clinical Trials Revenue Market Share by Therapeutic Area (2021–2026)
 Table 38. Global Patient Recruitment for Clinical Trials Forecasted Market Size by Therapeutic Area (US$ Million), 2027–2032
 Table 39. Global Patient Recruitment for Clinical Trials Revenue Market Share by Therapeutic Area (2027–2032)
 Table 40. North America Patient Recruitment for Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. North America Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2021–2026
 Table 42. North America Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2027–2032
 Table 43. Europe Patient Recruitment for Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Europe Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2021–2026
 Table 45. Europe Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2027–2032
 Table 46. Asia-Pacific Patient Recruitment for Clinical Trials Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (US$ Million), 2021–2026
 Table 48. Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (US$ Million), 2027–2032
 Table 49. Latin America Patient Recruitment for Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 50. Latin America Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2021–2026
 Table 51. Latin America Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2027–2032
 Table 52. Middle East & Africa Patient Recruitment for Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2021–2026
 Table 54. Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2027–2032
 Table 55. IQVIA Company Details
 Table 56. IQVIA Business Overview
 Table 57. IQVIA Patient Recruitment for Clinical Trials Product
 Table 58. IQVIA Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 59. IQVIA Recent Development
 Table 60. Thermo Fisher Scientific (PPD) Company Details
 Table 61. Thermo Fisher Scientific (PPD) Business Overview
 Table 62. Thermo Fisher Scientific (PPD) Patient Recruitment for Clinical Trials Product
 Table 63. Thermo Fisher Scientific (PPD) Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 64. Thermo Fisher Scientific (PPD) Recent Development
 Table 65. ICON plc Company Details
 Table 66. ICON plc Business Overview
 Table 67. ICON plc Patient Recruitment for Clinical Trials Product
 Table 68. ICON plc Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 69. ICON plc Recent Development
 Table 70. Syneos Health Company Details
 Table 71. Syneos Health Business Overview
 Table 72. Syneos Health Patient Recruitment for Clinical Trials Product
 Table 73. Syneos Health Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 74. Syneos Health Recent Development
 Table 75. Parexel Company Details
 Table 76. Parexel Business Overview
 Table 77. Parexel Patient Recruitment for Clinical Trials Product
 Table 78. Parexel Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 79. Parexel Recent Development
 Table 80. Labcorp Company Details
 Table 81. Labcorp Business Overview
 Table 82. Labcorp Patient Recruitment for Clinical Trials Product
 Table 83. Labcorp Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 84. Labcorp Recent Development
 Table 85. Medpace, Inc. Company Details
 Table 86. Medpace, Inc. Business Overview
 Table 87. Medpace, Inc. Patient Recruitment for Clinical Trials Product
 Table 88. Medpace, Inc. Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 89. Medpace, Inc. Recent Development
 Table 90. WCG Clinical Company Details
 Table 91. WCG Clinical Business Overview
 Table 92. WCG Clinical Patient Recruitment for Clinical Trials Product
 Table 93. WCG Clinical Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 94. WCG Clinical Recent Development
 Table 95. Science37 Company Details
 Table 96. Science37 Business Overview
 Table 97. Science37 Patient Recruitment for Clinical Trials Product
 Table 98. Science37 Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 99. Science37 Recent Development
 Table 100. Baidu Health Company Details
 Table 101. Baidu Health Business Overview
 Table 102. Baidu Health Patient Recruitment for Clinical Trials Product
 Table 103. Baidu Health Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 104. Baidu Health Recent Development
 Table 105. Hangzhou Tigermed Company Details
 Table 106. Hangzhou Tigermed Business Overview
 Table 107. Hangzhou Tigermed Patient Recruitment for Clinical Trials Product
 Table 108. Hangzhou Tigermed Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 109. Hangzhou Tigermed Recent Development
 Table 110. AutoCruitment Company Details
 Table 111. AutoCruitment Business Overview
 Table 112. AutoCruitment Patient Recruitment for Clinical Trials Product
 Table 113. AutoCruitment Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 114. AutoCruitment Recent Development
 Table 115. Beijing Houpu Pharmaceutical Company Details
 Table 116. Beijing Houpu Pharmaceutical Business Overview
 Table 117. Beijing Houpu Pharmaceutical Patient Recruitment for Clinical Trials Product
 Table 118. Beijing Houpu Pharmaceutical Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 119. Beijing Houpu Pharmaceutical Recent Development
 Table 120. Clariness Company Details
 Table 121. Clariness Business Overview
 Table 122. Clariness Patient Recruitment for Clinical Trials Product
 Table 123. Clariness Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 124. Clariness Recent Development
 Table 125. Matthews Media Group (MMG) Company Details
 Table 126. Matthews Media Group (MMG) Business Overview
 Table 127. Matthews Media Group (MMG) Patient Recruitment for Clinical Trials Product
 Table 128. Matthews Media Group (MMG) Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 129. Matthews Media Group (MMG) Recent Development
 Table 130. Trialbee Company Details
 Table 131. Trialbee Business Overview
 Table 132. Trialbee Patient Recruitment for Clinical Trials Product
 Table 133. Trialbee Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 134. Trialbee Recent Development
 Table 135. Publicis Company Details
 Table 136. Publicis Business Overview
 Table 137. Publicis Patient Recruitment for Clinical Trials Product
 Table 138. Publicis Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 139. Publicis Recent Development
 Table 140. Worldwide Clinical Trials Company Details
 Table 141. Worldwide Clinical Trials Business Overview
 Table 142. Worldwide Clinical Trials Patient Recruitment for Clinical Trials Product
 Table 143. Worldwide Clinical Trials Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 144. Worldwide Clinical Trials Recent Development
 Table 145. Elixia Company Details
 Table 146. Elixia Business Overview
 Table 147. Elixia Patient Recruitment for Clinical Trials Product
 Table 148. Elixia Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 149. Elixia Recent Development
 Table 150. Shanghai Jsure Company Details
 Table 151. Shanghai Jsure Business Overview
 Table 152. Shanghai Jsure Patient Recruitment for Clinical Trials Product
 Table 153. Shanghai Jsure Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 154. Shanghai Jsure Recent Development
 Table 155. JD Health Company Details
 Table 156. JD Health Business Overview
 Table 157. JD Health Patient Recruitment for Clinical Trials Product
 Table 158. JD Health Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 159. JD Health Recent Development
 Table 160. Waterdrop Inc. Company Details
 Table 161. Waterdrop Inc. Business Overview
 Table 162. Waterdrop Inc. Patient Recruitment for Clinical Trials Product
 Table 163. Waterdrop Inc. Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 164. Waterdrop Inc. Recent Development
 Table 165. Antidote Company Details
 Table 166. Antidote Business Overview
 Table 167. Antidote Patient Recruitment for Clinical Trials Product
 Table 168. Antidote Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
 Table 169. Antidote Recent Development
 Table 170. Research Programs/Design for This Report
 Table 171. Key Data Information from Secondary Sources
 Table 172. Key Data Information from Primary Sources
 Table 173. Authors List of This Report


List of Figures
 Figure 1. Patient Recruitment for Clinical Trials Picture
 Figure 2. Global Patient Recruitment for Clinical Trials Market Size Comparison by Clinical Trial Phase (US$ Million), 2021–2032
 Figure 3. Global Patient Recruitment for Clinical Trials Market Share by Clinical Trial Phase: 2025 vs 2032
 Figure 4. Phase I Features
 Figure 5. Phase II Features
 Figure 6. Phase III Features
 Figure 7. Phase IV Features
 Figure 8. Global Patient Recruitment for Clinical Trials Market Size Comparison by Client Type (US$ Million), 2021–2032
 Figure 9. Pharmaceutical and Biotechnology Companies Features
 Figure 10. CROs and Research Organizations Features
 Figure 11. Others Features
 Figure 12. Global Patient Recruitment for Clinical Trials Market Size Comparison by Recruitment Channel (US$ Million), 2021–2032
 Figure 13. Online Features
 Figure 14. Offline Features
 Figure 15. Global Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (US$ Million), 2021–2032
 Figure 16. Global Patient Recruitment for Clinical Trials Market Share by Therapeutic Area: 2025 vs 2032
 Figure 17. Oncology Case Studies
 Figure 18. Rare Disease Case Studies
 Figure 19. CNS and Psychiatric Case Studies
 Figure 20. Inflammatory Disorder Case Studies
 Figure 21. Infectious Disease Case Studies
 Figure 22. Others Case Studies
 Figure 23. Patient Recruitment for Clinical Trials Report Years Considered
 Figure 24. Global Patient Recruitment for Clinical Trials Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 25. Global Patient Recruitment for Clinical Trials Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 26. Global Patient Recruitment for Clinical Trials Market Share by Region: 2025 vs 2032
 Figure 27. Global Patient Recruitment for Clinical Trials Market Share by Players in 2025
 Figure 28. Global Patient Recruitment for Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 29. The Top 10 and 5 Players Market Share by Patient Recruitment for Clinical Trials Revenue in 2025
 Figure 30. North America Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. North America Patient Recruitment for Clinical Trials Market Share by Country (2021–2032)
 Figure 32. United States Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Canada Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Europe Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Europe Patient Recruitment for Clinical Trials Market Share by Country (2021–2032)
 Figure 36. Germany Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. France Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. U.K. Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Italy Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Russia Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Ireland Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Asia-Pacific Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Asia-Pacific Patient Recruitment for Clinical Trials Market Share by Region (2021–2032)
 Figure 44. China Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Japan Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. South Korea Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Southeast Asia Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. India Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Australia & New Zealand Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Latin America Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Latin America Patient Recruitment for Clinical Trials Market Share by Country (2021–2032)
 Figure 52. Mexico Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Brazil Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 54. Middle East & Africa Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 55. Middle East & Africa Patient Recruitment for Clinical Trials Market Share by Country (2021–2032)
 Figure 56. Israel Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 57. Saudi Arabia Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 58. UAE Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 59. IQVIA Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 60. Thermo Fisher Scientific (PPD) Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 61. ICON plc Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 62. Syneos Health Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 63. Parexel Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 64. Labcorp Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 65. Medpace, Inc. Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 66. WCG Clinical Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 67. Science37 Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 68. Baidu Health Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 69. Hangzhou Tigermed Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 70. AutoCruitment Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 71. Beijing Houpu Pharmaceutical Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 72. Clariness Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 73. Matthews Media Group (MMG) Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 74. Trialbee Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 75. Publicis Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 76. Worldwide Clinical Trials Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 77. Elixia Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 78. Shanghai Jsure Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 79. JD Health Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 80. Waterdrop Inc. Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 81. Antidote Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
 Figure 82. Bottom-up and Top-down Approaches for This Report
 Figure 83. Data Triangulation
 Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension